Home/Alpha-9 Oncology/Paul Blanchfield
PB

Paul Blanchfield

Chief Executive Officer

Alpha-9 Oncology

Therapeutic Areas

Alpha-9 Oncology Pipeline

DrugIndicationPhase
A9-3202Not Specified (Imaging Agent)Phase 1
A9-3408Not SpecifiedPhase 1